Exane Derivatives’s MSCI MSCI Stock Holding History

Exane Derivatives’s Portfolio MSCI Stock Details MSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$99.7K	Sell	242 -413	-63%	-$180K	0.06%	263
2022 Q1	$329K	Sell	655 -49	-7%	-$25.4K	0.09%	238
2021 Q4	$431K	Buy	704 +477	+210%	+$299K	0.1%	197
2021 Q3	$138K	Sell	227 -106	-32%	-$64.8K	0.03%	479
2021 Q2	$186K	Buy	333 +208	+166%	+$99.1K	0.04%	428
2021 Q1	$52.4K	Hold	125	–	–	0.02%	512
2020 Q4	$55.8K	Buy	+125	New	+$49K	0.02%	448

Other funds holding MSCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's MSCI Position: Q2 2022 in Review

Exane Derivatives reduced its MSCI (MSCI) stake by 63% in Q2 2022, selling an estimated $180K and leaving 242 shares worth $99.7K. The position accounts for 0.06% of the portfolio, ranked #263.

Exane Derivatives first reported a position in MSCI in Q4 2020 and has held it in 7 quarters since. The position peaked at $431K in Q4 2021. 747 funds tracked by Wall St. Rank hold MSCI as of Q2 2022.

Exane Derivatives held 242 shares of MSCI worth $99.7K as of Q2 2022.
Exane Derivatives sold 413 MSCI shares in Q2 2022, an estimated $180K.
MSCI made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #263 holding.
Exane Derivatives first reported a position in MSCI in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's MSCI position peaked at $431K in Q4 2021.
747 funds tracked by Wall St. Rank held MSCI as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.